Home > Implementing comprehensive HIV and HCV programmes with people who inject drugs: practical guidance for collaborative interventions.

United Nations Office on Drugs and Crime, International Network of People who Use Drugs, Joint United Nations Programme on HIV/AIDS, United Nations Development Programme, United Nations Population Fund, World Health Organization, United States Agency for International Development. (2017) Implementing comprehensive HIV and HCV programmes with people who inject drugs: practical guidance for collaborative interventions. Vienna: United Nations Office on Drugs and Crime. 175 p.

[img]
Preview
PDF (Implementing comprehensive HIV and HCV programmes) - Published Version
8MB

In all regions of the world, people who inject drugs are disproportionately affected by HIV.1 Globally, people who inject drugs are 28 times more likely to be living with HIV than the general population. The United Nations Office on Drugs and Crime (UNODC), the World Health Organization (WHO), the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Bank estimate that worldwide as of 2014, about 11.7 million2 people inject drugs, of whom an estimated 14% (1.6 million) are living with HIV.3 Injecting drug use accounts for 30% of new HIV infections outside sub- Saharan Africa. People who inject drugs also have higher rates of hepatitis C (HCV) and tuberculosis than the general population. The global rate of HCV among people who inject drugs is 52%, greatly surpassing even the high prevalence of HIV among them.

Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Opioid
Intervention Type:AOD disorder harm reduction
Date:2017
Pages:175 p.
Publisher:United Nations Office on Drugs and Crime
Corporate Creators:United Nations Office on Drugs and Crime, International Network of People who Use Drugs, Joint United Nations Programme on HIV/AIDS, United Nations Development Programme, United Nations Population Fund, World Health Organization, United States Agency for International Development
Place of Publication:Vienna
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:B Substances > Opioids (opiates) > Opioid product > Naloxone
B Substances > Opioids (opiates) > Opioid product > Methadone
G Health and disease > Etiology > Disease transmission factor > Needle sharing
G Health and disease > Disorder by cause > Communicable disease
G Health and disease > Disorder by cause > Communicable disease > HIV
G Health and disease > Disorder by cause > Communicable disease > Hepatitis C
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution)
J Health care, prevention and rehabilitation > Health related prevention > Health information and education > Communicable disease control > Needle distribution and exchange
VA Geographic area > International aspects

Repository Staff Only: item control page